Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 9 results for "Treatment For Multiple Sclerosis"

New Treatment for Multiple Sclerosis May Halt Disease Progression
Med India

New Treatment for Multiple Sclerosis May Halt Disease Progression

by Madhumathi Palaniappan on February 20, 2017 at 10:28 PM Health Watch Highlights Multiple sclerosis is a central nervous system disorder which affects the brain and spinal cord. Resetting the immune system by Autologous Hematopoietic Stem Cell ... Med India, 1 week ago

61 images for Treatment For Multiple Sclerosis

Med India, 1 week ago, 3 weeks ago
Unlimited Magazine, 3 weeks ago
Sydney Morning Herald, 3 weeks ago
Med India, 1 month ago
FiercePharma, 1 month ago
New Zealand Herald, 3 weeks ago, 3 weeks ago
New Zealand Herald, 3 weeks ago
HCPLive, 1 month ago
Med India

Multiple Sclerosis Drug Trigger Unpredictable Side Effects

Alemtuzumab drug prescribed for the treatment of multiple sclerosis was found to trigger unpredictable side effects in patients, reveals study.
 Med India1 month ago Ocrelizumab Drug For Multiple Sclerosis Treatment  Med India1 month ago Ocrelizumab Drug Shows Promising Results for the Treatment of Multiple Sclerosis  Med India1 month ago

Teva names interim CEO, new chairman as Vigodman steps down

Israel - based generic drugmaker Teva Pharmaceutical Industries Ltd said on Monday that Chief Executive Erez Vigodman was stepping down effective immediately and would be replaced on an interim basis by Yitzhak Peterburg, who has been chairman of Teva's board ...
 Sify2 weeks ago

Biogen to pay Forward Pharma $1.25 billion to protect MS drug

(Reuters) - Biogen Inc said on Tuesday it would pay Forward Pharma A/S $1.25 billion to license the Danish company's patents covering multiple sclerosis drugs, providing Biogen an insurance policy on future sales of Tecfidera, its blockbuster oral treatment ...
 Reuters1 month ago

Actelion's shares jump on report of Sanofi deal nearing

(Reuters) - Shares in Swiss biopharmaceuticals company Actelion surged more than 8 percent to a record high after Bloomberg reported that talks with French suitor Sanofi were nearing an agreement that could be worth about $275 per share. The potential deal, ...
 Sify2 months ago

Dealtalk: Trump's corporate tax holiday could spur pharma M&A

By Carl O'Donnell (Reuters) - U.S. President-elect Donald Trump's plan to incentivize U.S. companies to repatriate their swelling overseas cash piles could spur a new wave of dealmaking in a pharmaceutical industry seeking to buy its way into growth. For ...
 Sify2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less